Barclays »

Cytokinetics shares owned by Barclays

Quarter-by-quarter ownership of Cytokinetics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 1.2M 1.77
2023-09-30 $409k 475k 0.86

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Cytokinetics

Wolverine Asset Management
Weiss Asset Management LP[1
D. E. Shaw & Co
Balyasny Asset Management
Millennium Management
DeepCurrents Investment Group
Graham Capital Management
Point72 Asset Management
Readystate Asset Management
Polygon Management
CNH Partners
Jane Street
Partner Fund Management
Polar Securities
CSS

View all funds holding Cytokinetics